Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Medicinal Chemistry|February 4, 2018
Spirohydantoins and 1,2,4-triazole-3-carboxamide derivatives as inhibitors of histone deacetylase: Design, synthesis, and biological evaluationAlshimaa M A Aboeldahab, Eman A M Beshr, Mai E Shoman, et al.
Bioorganic Chemistry|March 17, 2022
Controlled microwave-assisted reactions: A facile synthesis of polyfunctionally substituted phthalazines as dual EGFR and PI3K inhibitors in CNS SNB-75 cell lineMaiiada Hassan Nazmy, Ramadan Ahmed Mekheimer, Mai E Shoman, et al.
Bioorganic Chemistry|June 8, 2020
Densely functionalized cinnolines: Controlled microwave-assisted facile one-pot multi-component synthesis and in vitro anticancer activity via apoptosis inductionMaiiada Hassan Nazmy, Ramadan Ahmed Mekheimer, Mai E Shoman, et al.
Pharmaceutics|November 11, 2022
Design, Preparation and Evaluation of Supramolecular Complexes with Curcumin for Enhanced Cytotoxicity in Breast Cancer Cell LinesHamdy Abdelkader, Adel Al Fatease, Zeinab Fathalla, et al.
Molecular Diversity|August 29, 2021
Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activitiesHossameldin A Aziz, Ahmed M M El-Saghier, Mohamed Badr, et al.
Chemical Biology & Drug Design|February 4, 2026
New Antiproliferative Pyrazole/Quinoline Hybrids: Design, Synthesis, and Biological Evaluation as EGFR InhibitorsMai E Shoman, Heba A Hassan, Hesham A M Gomaa, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2025
Design, synthesis, and biological evaluation of novel 1,5-diarylpyrazole carboxamides with dual inhibition of EGFR and COX-2 for the treatment of cancer and inflammatory diseasesOsama M Soltan, Salah A Abdel-Aziz, Kamal S Abdelrahman, et al.
Bioorganic Chemistry|July 25, 2017
New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liabilityHeba S Abd-Ellah, Mohamed Abdel-Aziz, Mai E Shoman, et al.
Molecular Diversity|February 19, 2020
New nicotinic acid-based 3,5-diphenylpyrazoles: design, synthesis and antihyperlipidemic activity with potential NPC1L1 inhibitory activityMai E Shoman, Moustafa O Aboelez, Montaser Sh A Shaykhon, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2024
Development of 1,5-diarylpyrazoles as EGFR/JNK-2 dual inhibitors: design, synthesis, moleecular docking, and bioactivity evaluationOsama M Soltan, Salah A Abdel-Aziz, Montaser Sh Shaykoon, et al.
Pageof 3